49,006
edits
Difference between revisions of "Nephrotic syndrome"
Jump to navigation
Jump to search
→Membranous nephropathy
(nl update) |
|||
| Line 151: | Line 151: | ||
===General=== | ===General=== | ||
*Presents as nephrotic syndrome. | *Presents as [[nephrotic syndrome]]. | ||
*Variable course. | *Variable course. | ||
*Pathogenesis: autoantibodies directed against ''phospholipase A2 receptor 1'', abbreviated PLA2R.<ref name=pmid22388552>{{Cite journal | last1 = Glassock | first1 = RJ. | title = The pathogenesis of membranous nephropathy: evolution and revolution. | journal = Curr Opin Nephrol Hypertens | volume = | issue = | pages = | month = Mar | year = 2012 | doi = 10.1097/MNH.0b013e3283522ea8 | PMID = 22388552 }}</ref><ref name=omim604939>{{OMIM|604939}}</ref> | *Pathogenesis: autoantibodies directed against ''phospholipase A2 receptor 1'', abbreviated PLA2R.<ref name=pmid22388552>{{Cite journal | last1 = Glassock | first1 = RJ. | title = The pathogenesis of membranous nephropathy: evolution and revolution. | journal = Curr Opin Nephrol Hypertens | volume = | issue = | pages = | month = Mar | year = 2012 | doi = 10.1097/MNH.0b013e3283522ea8 | PMID = 22388552 }}</ref><ref name=omim604939>{{OMIM|604939}}</ref> | ||